Trending News
Search results for: "Weight loss". 11 articles found.
In a collapsing world, artists like Slayyyter and Cobrah are chasing extreme highs with hyperactive music and debauched lyrics. Is their trashy vibe emancipating or a bit contrived? If any year demanded a soundtrack of self-aggrandising female mayhem, it's 2026. Amid the terrors of war, AI and the climate crisis, women are expected to be symbolic vessels of order and stability: thin, beautiful and perpetually 25 a state of perfection newly available for purchase thanks to weight-loss drugs and...
Eli Lilly's weight loss drug retatrutide helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight after two years.
An investigational obesity drug from Eli Lilly cleared important endpoints in a late-stage trial, the company said Thursday, by helping patients lose up to 30 percent of their body weight. Lilly said that a once-weekly injection of retatrutide met the primary endpoint in a phase 3 clinical trial, as well as key secondary endpoints for obesity, delivering clinically meaningful weight loss. The highest dose of retatrutide helped patients lose 28.3...
Drop your buffs because it's time to head to the buffet. At least, that's what we imagine Survivor's Rizo Velovic must have been thinking after competing on seasons 49 and 50 of the CBS reality...
Eli Lilly says participants in a sizable trial of retatrutide lost much more weight compared to other weight-loss drugs A new weight-loss drug has helped participants in a sizable trial lose much more weight than other obesity drugs already on the market up to an average of 28% of their body weight Eli Lilly announced Thursday. The Indiana-based pharmaceutical company in a press statement said that retatrutide, a once-weekly triple hormone receptor agonist, led to an average weight loss of 70.3lbs...
Remarkable new test results by drugmaker Eli Lilly reveal that their latest weight loss drug, retatrutide, may be even more effective than the three popular GLP-1s currently available. The new drug is designed to mimic three hormones responsible for hunger regulation and fat burning. NBC's medical contributor Dr. Natalie Azar breaks down the trial results and discusses how soon the new drug is likely to get FDA approval.
A new experimental shot from Eli Lilly may reset expectations for what a weight loss drug can do. In a large company-run trial, the injectable drug retatrutide helped people considered overweight or obese shed an average of 28% of their body weight over about a year and a half, with...
Eli Lilly's headquarters in Indianapolis.
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
Eli Lilly's highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news release Thursday...
GET IN TOUCH
About
Snips is the first performance-based influencer marketing platform that empowers influencers with business tools to grow their audience and monetize their social networks, while enabling brands to run performance-driven influencer programs built on true measurability & scale.